Sorafenib/SBRT Yields OS Benefit in Locally Advanced Hepatocellular Carcinoma

被引：0
|
作者：
Seymour, Caroline
机构：
来源：
ONCOLOGY-NEW YORK | 2023年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [21] Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
    Iwamoto, Hideki
    Niizeki, Takashi
    Nagamatsu, Hiroaki
    Ueshima, Kazuomi
    Nomura, Takako
    Kuzuya, Teiji
    Kasai, Kazuhiro
    Kooka, Yohei
    Hiraoka, Atsushi
    Sugimoto, Rie
    Yonezawa, Takehiro
    Ishihara, Akio
    Deguchi, Akihiro
    Arai, Hirotaka
    Shimose, Shigeo
    Shirono, Tomotake
    Nakano, Masahito
    Okamura, Shusuke
    Noda, Yu
    Kamachi, Naoki
    Sakai, Miwa
    Suzuki, Hiroyuki
    Aino, Hajime
    Matsukuma, Norito
    Matsugaki, Satoru
    Ogata, Kei
    Yano, Yoichi
    Ueno, Takato
    Kajiwara, Masahiko
    Itano, Satoshi
    Fukuizumi, Kunitaka
    Kawano, Hiroshi
    Noguchi, Kazunori
    Tanaka, Masatoshi
    Yamaguchi, Taizo
    Kuromatsu, Ryoko
    Kawaguchi, Atsushi
    Koga, Hironori
    Torimura, Takuji
    CANCERS, 2021, 13 (04) : 1 - 14
  • [22] Treatment of advanced hepatocellular carcinoma: beyond sorafenib
    Meyer, Tim
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (04): : 218 - 220
  • [23] SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Sacco, P. C.
    De Sanctis, R.
    Quadrini, S.
    Gori, B.
    Del, Signore E.
    Stumbo, L.
    Tedeschi, M.
    Falbo, P. T.
    Fulvi, A.
    Grassi, P.
    Sollami, R.
    Basile, M. L.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [24] Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
    Miyahara, Koji
    Nouso, Kazuhiro
    Yamamoto, Kazuhide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4151 - 4159
  • [25] Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
    Koji Miyahara
    Kazuhiro Nouso
    Kazuhide Yamamoto
    World Journal of Gastroenterology, 2014, (15) : 4151 - 4159
  • [26] Sorafenib for advanced-stage hepatocellular carcinoma
    Tomuleasa, Ciprian
    Cristea, Victor
    Irimie, Alexandru
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (03) : 346 - 347
  • [27] BENEFIT OF SORAFENIB ACCORDING TO UNDERLYING LIVER DISEASE ETIOLOGY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
    Bouattour, M.
    Goutte, N.
    Vullierme, M. -P.
    Castelnau, C.
    Farges, O.
    Faivre, S.
    Durand, F.
    Castera, L.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S407 - S407
  • [28] Correlation of skin toxicity and hypertension with clinical benefit in advanced hepatocellular carcinoma patients treated with sorafenib
    Shin, Sun Young
    Lee, Yu Jeung
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (11) : 837 - 846
  • [29] No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant
    Satapathy, Sanjaya K.
    Das, Kanak
    Kocak, Mehmet
    Helmick, Ryan A.
    Eason, James D.
    Nair, Satheesh P.
    Vanatta, Jason M.
    CLINICAL TRANSPLANTATION, 2018, 32 (05)
  • [30] Sorafenib Combined with Chemoembolization for Locally Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score Analysis
    Kim, Gun Ha
    Choi, Sang Lim
    Kim, Jin Hyoung
    Shim, Ju Hyun
    Alali, Meshari
    Kim, Nayoung
    LIFE-BASEL, 2021, 11 (10):
12345